
pmid: 16989816
LRP6 is a Wnt coreceptor at the cell surface. Here, we report that a specialized molecular chaperone Mesd modulates LRP6‐mediated Wnt signaling and how different LRP6 mutants exhibit differential effects on Wnt signaling. We found that overexpression of increasing amounts of the full‐length LRP6 enhances Wnt signaling in a dose dependent manner only in the presence of a co‐expression of the molecular chaperone Mesd, which promotes LRP6 folding and maturation to the cell surface. We also demonstrated that LRP6 mutant lacking the intracellular domain impedes LRP6 cell surface expression and Wnt signaling in a dominant‐negative fashion by sequestering Mesd from promoting LRP6 folding. Our results present novel mechanisms by which Mesd and LRP6 modulate Wnt signaling.
LRP6, Protein Folding, Mesd, Gene Expression, Chaperone, Wnt signaling, Cell Line, Wnt Proteins, Low Density Lipoprotein Receptor-Related Protein-6, Humans, LDL-Receptor Related Proteins, Molecular Chaperones, Signal Transduction
LRP6, Protein Folding, Mesd, Gene Expression, Chaperone, Wnt signaling, Cell Line, Wnt Proteins, Low Density Lipoprotein Receptor-Related Protein-6, Humans, LDL-Receptor Related Proteins, Molecular Chaperones, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 21 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
